Free Newsletter
SPOTLIGHT: Is Pfizer's CEO as bold as promised?
Like natives encountering a strange explorer in an old B movie, investors hailed Jeffrey Kindler (photo) when he was picked to succeed Pfizer CEO Hank McKinnell. Now, 19 months into his tenure, the natives are getting restless. Kindler hasn't delivered the kind of sweeping change he promised. Report






Click here to get the FierceBiotech email newsletter for FREE!
Be the first to comment